Search research articles
Contact Us
Filters
Showing results (791-800 of 3,162) with videos related to
Page
of 317
Sort By:
Antimicrobial Agents and Chemotherapy
|
January 1, 1986
Antistaphylococcal activity of ceforanide and cefonicid in the presence of human serum
A L Barry, R N Jones, R R Packer
Drugs
|
January 1, 1988
Cefotaxime single-dose surgical prophylaxis in a prepaid group practice. Comparisons with other cephalosporins and ticarcillin/clavulanic acid
R N Jones, J M Slepack, W V Wojeski
Diagnostic Microbiology and Infectious Disease
|
September 1, 1989
Statistical criteria for selecting quality control limits for broth microdilution susceptibility tests with 39 different antimicrobial agents. Collaborative Antimicrobial Susceptibility Testing Group
A L Barry, P C Fuchs, R N Jones
Diagnostic Microbiology and Infectious Disease
|
June 21, 2005
Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae
Ronald N Jones, Thomas R Fritsche, Helio S Sader
Antimicrobial Agents and Chemotherapy
|
November 26, 2003
Prevalence of extended-spectrum beta-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001
J M Bell, J D Turnidge, R N Jones, et al.
The Biochemical Journal
|
November 15, 1976
The electrophoretic properties and aggregation of mouse lymphoma cells, chinese-hamster fibroblasts and a somatic-cell hybrid
R G Greig, M N Jones, S R Ayad
Antimicrobial Agents and Chemotherapy
|
December 25, 2003
In vitro activities of the novel cephalosporin LB 11058 against multidrug-resistant Staphylococci and Streptococci
Helio S Sader, David M Johnson, Ronald N Jones
The Journal of Antimicrobial Chemotherapy
|
January 20, 2004
Comparisons of the in vitro susceptibility testing results for garenoxacin using six different national methods: report from the garenoxacin international bridging study
R N Jones, K A Gordon, D J Biedenbach
Diagnostic Microbiology and Infectious Disease
|
February 11, 2000
In vitro evaluation of cefepime and other broad-spectrum beta-lactams against bacteria from Indonesian medical centers. The Indonesia Antimicrobial Resistance Study Group
M T Lewis, D J Biedenbach, R N Jones
Diagnostic Microbiology and Infectious Disease
|
February 11, 2000
In vitro evaluation of cefepime and other broad-spectrum beta-lactams in Taiwan medical centers. The Taiwan Antimicrobial Resistance Study Group
D J Biedenbach, D M Johnson, R N Jones
Page
of 317
Search research articles
Search
Showing results (791-800 of 3,162) with videos related to
Sort By:
Page
of 317
Antimicrobial Agents and Chemotherapy
|
January 1, 1986
Antistaphylococcal activity of ceforanide and cefonicid in the presence of human serum
A L Barry, R N Jones, R R Packer
Drugs
|
January 1, 1988
Cefotaxime single-dose surgical prophylaxis in a prepaid group practice. Comparisons with other cephalosporins and ticarcillin/clavulanic acid
R N Jones, J M Slepack, W V Wojeski
Diagnostic Microbiology and Infectious Disease
|
September 1, 1989
Statistical criteria for selecting quality control limits for broth microdilution susceptibility tests with 39 different antimicrobial agents. Collaborative Antimicrobial Susceptibility Testing Group
A L Barry, P C Fuchs, R N Jones
Diagnostic Microbiology and Infectious Disease
|
June 21, 2005
Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae
Ronald N Jones, Thomas R Fritsche, Helio S Sader
Antimicrobial Agents and Chemotherapy
|
November 26, 2003
Prevalence of extended-spectrum beta-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001
J M Bell, J D Turnidge, R N Jones, et al.
The Biochemical Journal
|
November 15, 1976
The electrophoretic properties and aggregation of mouse lymphoma cells, chinese-hamster fibroblasts and a somatic-cell hybrid
R G Greig, M N Jones, S R Ayad
Antimicrobial Agents and Chemotherapy
|
December 25, 2003
In vitro activities of the novel cephalosporin LB 11058 against multidrug-resistant Staphylococci and Streptococci
Helio S Sader, David M Johnson, Ronald N Jones
The Journal of Antimicrobial Chemotherapy
|
January 20, 2004
Comparisons of the in vitro susceptibility testing results for garenoxacin using six different national methods: report from the garenoxacin international bridging study
R N Jones, K A Gordon, D J Biedenbach
Diagnostic Microbiology and Infectious Disease
|
February 11, 2000
In vitro evaluation of cefepime and other broad-spectrum beta-lactams against bacteria from Indonesian medical centers. The Indonesia Antimicrobial Resistance Study Group
M T Lewis, D J Biedenbach, R N Jones
Diagnostic Microbiology and Infectious Disease
|
February 11, 2000
In vitro evaluation of cefepime and other broad-spectrum beta-lactams in Taiwan medical centers. The Taiwan Antimicrobial Resistance Study Group
D J Biedenbach, D M Johnson, R N Jones
Page
of 317